Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-16ADPT144FRANCIS LO plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
FRANCIS LO filed Form 144 to notify SEC of plan to sell 142198 units of Adaptive Biotechnologies Corp securities around 2026-09-16, with aggregate market value of $3,793,842.64. The total outstanding units is 159595842.0. The amount planned to be sold represents 0.09% of total outstanding units; Recent transactions in ...
Mid CapBiotechnology
2026-09-16ARQT144Larry Todd Edwards plan to sell securities of Arcutis Biotherapeutics, Inc. under Form 144MEDIUM
Larry Todd Edwards filed Form 144 to notify SEC of plan to sell 341980 units of Arcutis Biotherapeutics, Inc. securities around 2026-09-16, with aggregate market value of $8,549,500.00. The total outstanding units is 125691961.0. The amount planned to be sold represents 0.27% of total outstanding units; ...
Mid CapBiotechnology
2026-09-16CBIO144Jonathan McNeill plan to sell securities of Crescent Biopharma, Inc. under Form 144MEDIUM
Jonathan McNeill filed Form 144 to notify SEC of plan to sell 804 units of Crescent Biopharma, Inc. securities around 2026-09-16, with aggregate market value of $15,115.20. The total outstanding units is 37143940.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3...
Small CapBiotechnology